PREFER - Why, when and how to assess and use patient preferences in medical product decision-making

New upload

Community



PREFER - Why, when and how to assess and use patient preferences in medical product decision-making

PREFER is a public-private research project where academic researchers, HTA, patient organisations, and the pharmaceutical industry work together to find out when, and how patients’ treatment preferences can be used in medical product development. We include patient stakeholders at every level of the project. Developing a set of recommendations to support development of guidelines for industry, Regulatory Authorities and HTA bodies.

 

The Patient Preferences in Benefit-Risk Assessments during the Drug Life Cycle (PREFER) project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 115966. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The publications in this Zenodo community reflects the authors’ and the PREFER project's view, and not the view of IMI, the European Union or EFPIA.


Curated by:
PREFER
Curation policy:
Not specified
Created:
September 10, 2021
Harvesting API:
OAI-PMH Interface

Want your upload to appear in this community?

  • Click the button above to upload a record directly to this community.
    To add one of your existing records to the community, edit the record, add this community under the "Communities" section, save, and finally publish.
  • The community curator will then be notified to either accept or reject your upload (see community curation policy below).
  • If your upload is rejected by the curator, it will still be available on Zenodo, just not in this community.